The genes that contribute to the genetic susceptibility to chronic obstruct
ive pulmonary disease (COPD) remain largely unknown. We hypothesized that w
idely divergent rates of decline in lung function in smokers would be a rob
ust phenotype for detection of genes that contribute to COPD severity. We s
elected 283 rapid decliners (Delta FEV1 = -154 +/- 3 ml/yr) and 308 nondecl
iners (Delta FEV1 = + 15 +/- 2 ml/yr) from among smokers followed for 5 yr
in the NHLBI Lung Health Study. Rapid decline of FEV1 was associated with t
he MZ genotype of the alpha (1)-antitrypsin gene (odds ratio [OR] = 2.8, p
= 0.03). This association was stronger for a combination of a family histor
y of COPD with MZ (OR = 9.7, p = 0.03). These data suggest that the MZ geno
type results in an increased rate of decline in lung function and interacts
with other familial factors. Haplotype frequencies of the microsomal epoxi
de hydrolase (mEH) gene were significantly different between rapid decliner
s and nondecliners (p = 0.03). A combination of a family history of CORD wi
th homozygosity for the His(113)/His(139)mEH haplotype was also associated
with rapid decline of lung function (OR = 4.9, p = 0.04). The alpha (1)-ant
itrypsin S and 3' polymorphisms, vitamin D-binding protein isoforms, and tu
mor necrosis factor (TNF-alpha G-308A and TNF-beta A252G) polymorphisms wer
e not associated with rate of decline of lung function.